Show simple item record

dc.contributor.authorRichardson, Kathryn
dc.contributor.authorFox, Chris
dc.contributor.authorMaidment, Ian
dc.contributor.authorSteel, Nicholas
dc.contributor.authorLoke, Yoon K.
dc.contributor.authorArthur, Antony
dc.contributor.authorMyint, Phyo K
dc.contributor.authorGrossi, Carlota M.
dc.contributor.authorMattishent, Katharina
dc.contributor.authorBennett, Kathleen
dc.contributor.authorCampbell, Noll L.
dc.contributor.authorBoustani, Malaz
dc.contributor.authorRobinson, Louise
dc.contributor.authorBrayne, Carol
dc.contributor.authorMatthews, Fiona E.
dc.contributor.authorSavva, George M.
dc.date.accessioned2018-04-30T08:48:09Z
dc.date.available2018-04-30T08:48:09Z
dc.date.issued2018-04-25
dc.identifier.citationRichardson , K , Fox , C , Maidment , I , Steel , N , Loke , Y K , Arthur , A , Myint , P K , Grossi , C M , Mattishent , K , Bennett , K , Campbell , N L , Boustani , M , Robinson , L , Brayne , C , Matthews , F E & Savva , G M 2018 , ' Anticholinergic drugs and risk of dementia : case-control study ' , BMJ , vol. 361 , k1315 . https://doi.org/10.1136/bmj.k1315en
dc.identifier.issn0959-8146
dc.identifier.otherPURE: 119171514
dc.identifier.otherPURE UUID: 68a5ff01-69d3-4918-b567-73d46a812961
dc.identifier.otherPubMed: 29695481
dc.identifier.otherPubMedCentral: PMC5915701
dc.identifier.otherScopus: 85045969637
dc.identifier.urihttp://hdl.handle.net/2164/10384
dc.descriptionWe thank Ms Tarita Murray-Thomas (Medicines and Healthcare products Regulatory Agency) for extracting the CPRD data, Mr Keshav Bajaj (Aston University) for assisting with drugs coding, and Prof Ryan Carnahan for providing the Anticholinergic Drug Scale (ADS). We thank Mr Barry Plumpton, Mrs Ann McLauchlan, Mrs Barbara di Vita, and Mrs Gloria Swan for their assistance and oversight as Alzheimer’s Society Research Network Volunteers. Funding: This research was supported by the Alzheimer’s Society (AS-PG-2013-017). The funders had no role is the design of the study or the interpretation of the findings.en
dc.format.extent12
dc.language.isoeng
dc.relation.ispartofBMJen
dc.rightsThis is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.en
dc.subjectR Medicine (General)en
dc.subjectSupplementary Dataen
dc.subject.lccR1en
dc.titleAnticholinergic drugs and risk of dementia : case-control studyen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1136/bmj.k1315


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record